期刊文献+

STAT1 mRNA在鼻咽癌组织中的表达及其临床意义 被引量:3

The expression and clinical significance of STAT1 mRNA in nasopharyngeal carcinoma tissues
下载PDF
导出
摘要 目的检测信号转导子和转录激活子1(STAT1)在鼻咽癌中的表达,探讨其在鼻咽癌发生过程中的作用及其临床意义。方法采用SYBR GreenI荧光定量RT-PCR技术对48例鼻咽癌组织和12例慢性鼻咽炎组织中STAT1 mRNA的表达进行检测,并分析其表达情况与临床病理资料的相关性。结果鼻咽癌癌组织中STAT1 mRNA的表达水平明显高于慢性鼻咽炎组织(P<0.05);在肿瘤TNM分期中,T3+T4期癌组织STAT1 mRNA表达水平明显高于T1+T2期(P<0.05);在临床分期中,Ⅲ+Ⅳ期癌组织STAT1 mRNA表达水平明显高于Ⅰ+Ⅱ期(P<0.05);而其表达与有无淋巴结转移无明显相关(P>0.05)。结论 STAT1 mRNA在鼻咽癌组织中高表达,其表达增强可能与鼻咽癌的发生和发展相关,可作为鼻咽癌恶性潜能的检测指标之一。 Objective To investigate the expressionof STAT1 and itscorrelationwiththe clinical pathological parameters in nasopharyngeal carcinoma,and to reveal the potential mechanism of STAT1 underlying nasopharyngeal carcinoma.Methods The technique of quantitative reverse transcription polymerasechain reaction was applied to detect the STAT1 mRNA expression in 48 cases of nasopharyngeal carcinomatissues and 12 cases of normal nasopharyngeal mucosa.mRNA expression level of STAT1 in different groups was compared statistically.Results The expression of STAT1 mRNA was significantly higher in nasopharyngeal carcinoma tissues than that in normal nasopharyngeal mucosa(P 0.05),Besides,the relative mRNA expression of STAT1 was significantly higher in stage T3 + T4 cancer group than that in stage T1 + T2 group(P 0.05),and was significantly higher in clinical stage Ⅲ + Ⅳ cancer group than that in stage Ⅰ + Ⅱ group(P 0.05),but no association with lymphocyte metastasis(P 0.05).Conclusion STAT1 mRNA expression up-regulated in nasopharyngeal carcinoma might relates to tumor occurrence and development,which may serve as a biomarker for invasiveness of nasopharyngeal carcinoma.
出处 《中国实用医药》 2012年第30期1-3,共3页 China Practical Medicine
基金 广东省医学科研基金项目(项目编号:B2011281) 广州市医药卫生科技项目(项目编号:2009-YB-113 201102A213178)
关键词 鼻咽癌 STAT1 荧光定量PCR Nasopharyngeal carcinoma STAT1 Reverse transcriptase polymerase chain reaction
  • 相关文献

参考文献13

  • 1Caponigro F,Longo F,Ionna F,et al.Treatment approaches to nasopharyn-geal carcinoma:a review.Anticancer Drugs,2010,21(5):471-477.
  • 2Bowman T,Garcia R,Turkson J,et al.STATs in oncogenesis.Oncogene,2000,19(21):2474-2488.
  • 3Boudn(y) V,Kocák I,Lauerová L,et al.Interferon inducibility of STAT1 activation and its prognostic significance in melanoma patients.Folia Biol (Praha),2003,49(4):142-146.
  • 4吴琼,王红,聂玉强,李瑜元,夏金堂,杨劭宇,张伟健.信号转导子和转录激活子1在大肠癌中的表达及其意义[J].实用医学杂志,2009,25(17):2803-2805. 被引量:1
  • 5Yuan JS,Reed A,Chen F,et al.Statistical analysis of real-time PCR data.BMC Bioinformatics,2006,22(7):85.
  • 6Youlyouz-Marfak I,Gachard N,Le Clorennec C,et al.Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents Cell Death Differ,2008,15(2):376-385.
  • 7Kim HS,Lee MS.STAT1 as a key modulator of cell death.Cell Signal,2007,19(3):454-465.
  • 8Ramana CV,Grammatikakis N,Chernov M,et al.Regulation of c-myc expression by IFN-γ through Stat1-dependent and-independent pathways.EMBO J,2000,19(2):263-272.
  • 9Townsend PA,Scarabelli TM,Davidson SM,et al.STAT1 interacts with p53 to enhance DNA damage-induced apoptosis.J Biol Chem,2004,279:5811-5820.
  • 10Adámková L,Soucková K,Kovarík J.Transcription protein STAT1:biology and relation to cancer.Folia Biol,2007:53(1):1-6.

二级参考文献7

  • 1周钧,钟德玝,杨竹林,胡继雄,邓星辉.STAT_1、STAT_2、STAT_4在原发性肝癌中的表达及意义[J].中华肝胆外科杂志,2004,10(12):838-840. 被引量:5
  • 2Ramana C V, Grammatikakis N, Chemov M, et al. Regulation of c- myc expression by IFN-through Statl-dependent and independent pathways [J]. EMBO J,2000,19(2):263-272.
  • 3Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis [J]. Oncogene,2000,19 ( 21 ) :2474-2488.
  • 4Boudny V, Kocak I, Lauerova L, et al. Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients [J]. Folia Biol (Praha),2003,49(4):142-146.
  • 5Lee C K, Gimeno R, Levy D E. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes [J]. J Exp Med, 1999,190 ( 10 ): 1451 - 1464.
  • 6Ouchi T, Lee S W, Ouchi M, et al. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-garmna target genes [J]. Proc Natl Acad Sci U S A, 2000, 97 ( 10 ) :5208 -5213.
  • 7俞丽芬,吴云林.信号传导及转录活化因子STAT与消化系统疾病的关系[J].世界华人消化杂志,2004,12(5):1196-1201. 被引量:6

同被引文献26

  • 1Stark GR,Darnell JE Jr.The JAK-STAT pathway at twenty[J].Immunity,2012,36(4):503-514.
  • 2Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61 (2):69-90.
  • 3Zimmerman MA,Rahman NT,Yang D,et al.Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance[J].Cancer Res,2012,72(18):4724-4732.
  • 4Adámková L,Soucková K,Kovarík J.Transcription protein STAT1:biology and relation to cancer[J].Folia Biol (Praha),2007,53 (1):1-6.
  • 5Youlyouz-Marfak I,Gachard N,Le Clorennec C,et al.Identifica tion of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents[J].Cell Death Differ,2008,15 (2):376-385.
  • 6Townsend PA,Scarabelli TM,Davidson SM,et al.STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis[J].J Biol Chem,2004,279(7):5811-5820.
  • 7Ramana CV,Grammatikakis N,Chernov M,et al.Regulation of c-myc expression by IFN-gamma through Stat1-dependent and independent pathways[J].EMBO J,2000,19 (2):263-272.
  • 8Klampfer L.The role of signal transducers and activators of transcription in colon cancer[J].Front Biosci,2008,13 (1):2888-2899.
  • 9Huang S,Bucana CD,Van Arsdall M,et al.Stat1 negatively regulates angiogenesis,tumorigenicity and metastasis of tumor cells[J].Oncogene,2002,21 (16):2504-2512.
  • 10Yue Y,Zhong W, Pei G, et al. Aberrant activation of Hedgehog pathway in Nasopharyngeal carcinoma [ J ]. Clin Exp Med, 2013, 13:315-322.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部